Increasing Academic and Commercial R&D Spending on Pharmaceuticals
The pharmaceutical industry holds the largest market share for the chromatography resins market hence, the worldwide fluctuations in the pharmaceutical industry directly affect the demand for chromatography resins. In this industry, chromatography resins are used for a wide variety of applications, including separation of chemical biomolecules, drug delivery, protein purification, diagnostics etc. With the increasing number of diseases, like AIDS, and cancer research, and the discovery of new viruses and bacteria, industries have called for the development of newer molecular entities (NMEs) and have increased their R&D spending on medicines. With the rising critical diseases across the world, monoclonal antibody therapeutics is quickly gaining importance, which is directly employing the use of chromatography resins.
Water and Environmental Analysis to Expand at the Fastest Rate
Chromatography resins application for the analysis of water and environment is considered to be essential in the modern day treatment process. These resins are highly porous in nature, hence they are widely used for the testing of quality of air, water, and soil. Chromatography resins, especially ion-exchange chromatography resins, are widely applied in the air purification technique, as they offer a large surface area to entrap high concentration of air pollutants. Ion-exchange chromatography resins also aids in soil testing process, by accurately determining different elements that are available in soil.
Germany to Dominate the Market
In 2017, Germany held the highest market share, accounting for around 24% of the European market. The German market is highly driven by the pharmaceutical industry. In Europe, the German pharmaceutical industry is the largest and fourth largest in the world. In 2016, the domestic demand decreased in the country, however, the exports of pharmaceutical products have increased, significantly. The demand for chromatography resins from the pharmaceutical industry is expected to be moderate, due to a decrease in the domestic demand. However, the exports are likely to contribute to the demand of these resins in the region.
Key Developments in the Market
- November 2017: Purolite collaborated with Repligen Corporation, involved in the line of pre-packed chromatography columns.
Reasons to Purchase this Report
- Role of the pharmaceutical industry in the market growth
- Various market perspectives, with the help of Porter’s five forces analysis
- The dominating application and technology during the forecast period
- The fast growing countries during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
- 3 months analyst support, along with the Market Estimate sheet (in excel).
1.1 Research Phases
1.2 Study Deliverables
1.3 Scope of the Report
2. Executive Summary
3. Market Insights
3.1 Industry Value Chain Analysis
3.2 Industry Attractiveness - Porter’s Five Forces Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Consumers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitute Products and Services
3.2.5 Degree of Competition
4. Market Dynamics
4.1.1 Increasing Academic and Commercial R&D Spending On Pharmaceuticals
4.1.2 Technological Advancements in Chromatography Resins
4.2.1 High Costs vs. Productivity of Chromatography Systems
4.3.1 Rising Importance of Green Chromatography
4.3.2 Other opportunities
5. Market Segmentation and Analysis (Market Size, Forecast & CAGR)
5.1 By Application
188.8.131.52 Drug Discovery
184.108.40.206 Drug Production
5.1.2 Food & Beverages
5.1.3 Water & Environmental Analysis
5.2 By Technology
5.2.1 Ion Exchange Chromatography Resins
5.2.2 Affinity Chromatography Resins
5.2.3 Size Exclusion Chromatography Resins
5.2.4 Hydrophobic Interaction Chromatography Resins
5.2.5 Mixed-Mode Chromatography Resins
5.3 By Origin
220.127.116.11 Silica Gel
18.104.22.168 Aluminium Oxide
6. Regional Analysis (Market Size, Forecast & CAGR)
6.6 Rest of Europe
7. Competitive Landscape
7.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
7.2 Market Share Analysis**
7.3 Strategies Adopted by Leading Players
8. Company Profiles (Overview, Financials**, Products & Services, Recent Developments and Analyst View)
8.1 Agilient Technologies
8.2 Avantor Performance Materials, Inc.
8.3 Bio-Rad Laboratories, Inc.
8.4 GE Healthcare Life Sciences
8.5 Merck KGaA
8.6 Mitsubishi Chemical Corporation
8.7 Pall Corporation
8.8 Perkinelmer, Inc.
8.10 Repligen Corporation
8.11 The Dow Chemical Company
8.12 Thermo Fisher Scientific, Inc.
8.13 Tosoh Bioscience LLC
*list not exhaustive
**subject to availability on public domain
- Agilient Technologies
- Avantor Performance Materials Inc.
- Bio-Rad Laboratories Inc.
- GE Healthcare Life Sciences
- Merck KGaA
- Mitsubishi Chemical Corporation
- Pall Corporation
- Perkinelmer Inc.
- Repligen Corporation
- The Dow Chemical Company
- Thermo Fisher Scientific Inc.